Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap6.18B
Enterprise Value5.91B
P/E Ratio97.89
PEG Ratio-4.41
Price/Sales Ratio7.05
Price/Book Ratio3.26
Enterprise/Revenue6.73
Enterprise/EBITDA42.32

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.07
Operating Margin0.09
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.03

Income Statement

Revenue827.14M
Revenue/Share1.91
Gross Profit474.67M
EBITDA165.69M
Net Income65.09M
Diluted EPS0.16

Balance Sheet

Total Cash607.04M
Total Cash/Share1.45
Total Debt40.92M
Total Debt/Equity0.02
Current Ratio4.68
Book Value Per Share4.16

Price History

52-Week Change-17.3
52-Week High21.52
52-Week Low11.42
Moving Average 50 Days13.12
Moving Average 200 Days14.88

Statistics

Average Volume3.75M
Shares Outstanding417.6M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.08
Trailing Annual Dividend Yield0.56
Payout Ratio0.36
Last Split FactorN/A
Last Split DateN/A
AD